ICU Medical officer plans $819K stock sale

An ICU Medical officer has filed a Rule 144 notice to resell 4,856 vested common shares through a brokerage firm.

Rhea-AI Filing Summary

ICU Medical Inc. (ICUI) has a notice filed under Rule 144 for a proposed resale of its common stock by company officer Virginia Ruth Sanzone. The notice covers 4,856 shares of common stock to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services on NASDAQ.

The shares were acquired upon the vesting of Restricted Stock and Performance Shares during the period from March 15, 2024 through March 15, 2026, with an indicated aggregate market value of approximately $819,150.33 tied to the proposed sale quantity.

Key Figures

Shares to be sold: 4,856 shares of common stock Aggregate market value: $819,150.33 Acquisition period for shares: March 15, 2024 to March 15, 2026 +1 more

4 metrics

Shares to be sold 4,856 shares of common stock Quantity of ICU Medical shares covered by the Rule 144 notice

Aggregate market value $819,150.33 Indicated value tied to 4,856 shares to be sold

Acquisition period for shares March 15, 2024 to March 15, 2026 Period during which Restricted Stock and Performance Shares vested

Date of notice September 3, 2026 Date on which the Rule 144 notice is dated

Key Terms

Rule 144, Restricted Stock, Performance Shares

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock financial

"acquired upon the vesting of Restricted Stock and Performance Shares"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Performance Shares financial

"acquired upon the vesting of Restricted Stock and Performance Shares"

Performance shares are a type of company stock given to executives or employees that only become theirs if the company meets specific goals, like hitting certain profits or growth targets. They motivate leaders to work toward the company’s success, because their additional shares depend on achieving these results.

FAQ

What does the Form 144 filing disclose for ICUI?

It discloses that Virginia Ruth Sanzone, an officer of ICU Medical Inc. (ICUI), has filed a Rule 144 notice for the proposed resale of 4,856 shares of common stock, to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services on NASDAQ.

How many ICUI shares are covered by Virginia Sanzone’s Rule 144 notice?

The Rule 144 notice covers 4,856 shares of ICU Medical common stock for potential resale. The filing associates these shares with an indicated aggregate market value of about $819,150.33 for the proposed transaction.

How were the ICUI shares in this Form 144 acquired?

The filing states the shares to be sold were acquired upon the vesting of Restricted Stock and Performance Shares during the period from March 15, 2024 through March 15, 2026.

Which broker is involved in the proposed ICUI share sale?

The proposed sale of ICU Medical (ICUI) shares listed in the Form 144 is to be effected through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004.

What is the approximate aggregate value of ICUI shares in this Form 144?

The filing indicates an aggregate market value of about $819,150.33 associated with the 4,856 shares of ICU Medical common stock covered by the Rule 144 notice.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/03/2026 - 04:03 PM Accepted by SEC EDGAR 09/03/2026 - 04:02 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001669639
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ICU MEDICAL, INC.
SEC File Number	001-34634
Address of Issuer	951 Calle Amanecer San Clemente CALIFORNIA 92673
Phone	(949) 366-2183
Name of Person for Whose Account the Securities are To Be Sold	VIRGINIA SANZONE
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	4856	819150.33	25007038	09/03/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/15/2024	Performance and Restricted Stock	ISSUER			4856	03/15/2024	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	The securities to be sold were acquired upon the vesting of Restricted Stock and Performance Shares during the period of 03/15/2024 through 03/15/2026.
Date of Notice	09/03/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/04/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Virginia Ruth Sanzone
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)